Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy

被引:3
|
作者
Minakata, Tomokazu [1 ]
Nakano, Yoshio [2 ]
Tamura, Shinobu [3 ]
Kazuki, Yamanishi [2 ]
Hayakawa, Kana [2 ]
Hayakawa, Takahiro [2 ]
Oota, Takayuki [2 ]
Fuzimoto, Tokuzou [2 ]
Yamano, Yukiko [1 ]
Takii, Takemasa [4 ]
机构
[1] Kinan Hosp, Dept Nephrol, Wakayama, Japan
[2] Kinan Hosp, Dept Internal Med, Wakayama, Japan
[3] Wakayama Med Univ, Dept Internal Med, Div Hematol, Wakayama, Japan
[4] Japan AntiTB Assoc, Dept Mycobacteriol, Res Inst TB, Tokyo, Japan
关键词
tuberculous spondylitis; Mycobacterium bovis; bacillus Calmette-Guerin; BOVIS VERTEBRAL OSTEOMYELITIS; BCG THERAPY; COMPLICATION; BLADDER; DISEASE;
D O I
10.2169/internalmedicine.3288-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 74-year-old man underwent intravesical bacillus Calmette-Guerin (BCG) therapy for bladder cancer and later presented with lower left back pain. Magnetic resonance imaging of the spine showed high signal intensity, diagnosed as a cystic lesion in the epidural and bilateral intestinal psoas muscle. A computed tomography-guided needle biopsy and histological examination revealed bacteria from the family Mycohacteriaceae, and Mycobacterium bovis was identified using multiplex polymerase chain reaction. If lower back pain appears in a patient who has undergone BCG therapy, it is necessary to test for tuberculous spondylitis. In addition, QuantiFERON is useful for the differential diagnosis of M. bovis BCG infection.
引用
收藏
页码:733 / 737
页数:5
相关论文
共 50 条
  • [21] Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation
    Ohata, Hiroki
    Prakasa, David
    Goto, Hiroyuki
    Ohata, Kenji
    Goto, Takeo
    Nishikawa, Misao
    [J]. JOURNAL OF CRANIOVERTEBRAL JUNCTION AND SPINE, 2021, 12 (03): : 318 - 321
  • [22] The quality of life during intravesical bacillus Calmette-Guerin therapy
    Bohle, A
    Balck, F
    vonWietersheim, J
    Jocham, D
    [J]. JOURNAL OF UROLOGY, 1996, 155 (04): : 1221 - 1226
  • [23] Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy
    Özbakkaloǧlu B.
    Tünger Ö.
    Sürücüoǧlu S.
    Lekili M.
    Kandiloglu A.R.
    [J]. International Urology and Nephrology, 1999, 31 (1) : 49 - 53
  • [24] Managing the adverse events of intravesical bacillus Calmette-Guerin therapy
    Decaestecker, Karel
    Oosterlinck, Willem
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2015, 7 : 157 - 163
  • [25] Tuberculous Orchitis Following Intravesical Bacille Calmette-Guerin (BCG) Therapy
    Klebanov, Nikolai
    Raghavan, Aravind
    [J]. CUREUS, 2018, 10 (05):
  • [26] INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS FAILING STANDARD INTRAVESICAL CHEMOTHERAPY
    KACHEL, TA
    HENEY, NM
    GRIFFIN, PP
    YOUNG, RH
    [J]. JOURNAL OF UROLOGY, 1987, 137 (04): : A179 - A179
  • [27] SYSTEMIC BACILLUS CALMETTE-GUERIN INFECTION, BCGITIS, IN PATIENTS TREATED BY INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR BLADDER-CANCER
    STEG, A
    LELEU, C
    DEBRE, B
    BOCCONGIBOD, L
    SICARD, D
    [J]. EUROPEAN UROLOGY, 1989, 16 (03) : 161 - 164
  • [28] INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER - EFFECT OF BACILLUS CALMETTE-GUERIN VIABILITY ON TREATMENT RESULTS
    KELLEY, DR
    RATLIFF, TL
    CATALONA, WJ
    SHAPIRO, A
    LAGE, JM
    BAUER, WC
    HAAFF, EO
    DRESNER, SM
    [J]. JOURNAL OF UROLOGY, 1985, 134 (01): : 48 - 53
  • [29] Intravesical Bacille Calmette-Guerin therapy
    Azuma, Takeshi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (06) : 538 - 538
  • [30] BCGitis: A rare case of tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guerin therapy
    Demers, Virginie
    Pelsser, Vincent
    [J]. JOURNAL OF RADIOLOGY CASE REPORTS, 2012, 6 (11): : 16 - 21